"Dose or Strength to be Studied" in ICH M13A [Regulatives / Guidelines]

posted by Darborn – Taiwan, 2024-10-08 02:58 (276 d 23:54 ago) – Posting: # 24223
Views: 2,130

Thanks BEQool for the reply,

I totally agree with your point that a separate paragraph will be needed if it truly means that all high-risk products should be conducting those studies. However, this still needs to be clarified by the authorities. :yes:

Best regard

Complete thread:

UA Flag
Activity
 Admin contact
23,434 posts in 4,931 threads, 1,674 registered users;
38 visitors (0 registered, 38 guests [including 16 identified bots]).
Forum time: 02:53 CEST (Europe/Vienna)

For every expert there is an equal and opposite expert.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5